|
|
| Research article summary (published 17 Feb 2008): |
Increased detection of HIV-specific T cell responses by combination of central sequences with comparable immunogenicity.
Full Abstract
OBJECTIVE:
To evaluate the recognition of computationally designed, centralized HIV-1 antigens derived from clade B, C and group M sequences by individuals infected with HIV-1-M clades B and C.
METHODS:
Three centralized sequences have been described - consensus, ancestor and center-of-tree - each of which attempts to minimize the genetic distance to circulating viruses. It is unclear whether any of these sequences affords an advantage for T cell recognition. The ability of centralized clade B and C and group M peptides to be targeted in ELISpot assays was assessed using samples from the United States, Peru, Barbados and South Africa.
RESULTS:
Each of the clade-specific centralized peptide sets was equally powerful in detecting cytotoxic T cell (CTL) responses. Importantly, combination of these sets detected significantly broader responses. Although broad responses were observed in populations from which few sequences informed the design of these centralized sequences, the genetic distance between local sequences and the respective test set was inversely associated with response rates. Furthermore, the CTL reactivity in clade C-infected subjects using clade B peptides was reduced relative to within-clade peptide responses, while responses to group M peptides were comparable to within-clade peptide responses in these individuals.
CONCLUSIONS:
All tested centralized antigens provided a similarly potent set of antigenic peptides. However, the significantly broader responses detected using the combination of sets highlight the importance of maximizing coverage of HIV-1 sequence diversity in vaccine preparations, as well as in the evaluation of CTL responses in HIV-1-infected individuals and those vaccinated.
Learn Faster Today Improve your study skills
Author information
Author/s: Frahm, Nicole (N); Nickle, David C (DC); Linde, Caitlyn H (CH); Cohen, Daniel E (DE); Zuņiga, Rosario (R); Lucchetti, Aldo (A); Roach, Timothy (T); Walker, Bruce D (BD); Allen, Todd M (TM); Korber, Bette T (BT); Mullins, James I (JI); Brander, Christian (C);
Affiliation: Partners AIDS Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02129-2000, USA. nfrahm(-atsign-)partners.org
Grants: N01-AL-15422 (Agency:United States PHS) ; N01-AL-30024 (Agency:United States PHS) ; P01-AI-57005 (Agency:United States NIAID) ; P30-AI-27757 (Agency:United States NIAID) ; R01-A1-067077 (Agency:United States PHS)
Journal and publication information
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal: AIDS (London, England) (AIDS), published in England. (Language: eng)
Reference: 2008-Feb; vol 22 (issue 4) : pp 447-56
Dates: Created 2008/02/27; Completed 2008/08/04;
PMID: 18301057, status: MEDLINE (last retrieval date: 11/6/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
|
Related articles
These are the highest related articles currently in the database:
- Differential immunogenicity of HIV-1 clade C proteins in eliciting CD8+ and CD4+ cell responses.
28 Sep 2005 - A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates.
29 Jun 2005 - HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
12 Sep 2007 - Increased sequence diversity coverage improves detection of HIV-specific T cell responses.
13 Nov 2007 - Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector.
6 Nov 2006 - Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus.
29 Jun 2005 - Induction of HIV-specific memory T-cell responses by topical DermaVir vaccine.
20 Jan 2007 - Different levels of immunogenicity of two strains of Fowlpox virus as recombinant vaccine vectors eliciting T-cell responses in heterologous prime-boost vaccination strategies.
29 Jun 2006 - Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine.
16 Aug 2005 - Rational design of a plasmid DNA vaccine capable of eliciting cell-mediated immune responses to multiple HIV antigens in mice.
17 Aug 2005
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.